Redhill Biopharma Ltd.

(RDHL) Trade

By |

Profile

Redhill Biopharma Ltd is a specialty biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary drugs for the treatment of gastrointestinal diseases. RedHill's pipeline includes several drug candidates in advanced clinical development stages, including three Phase III-stage programs. Its late clinical-stage pipeline includes TALICIA(r) (RHB-105), RHB-104, RHB-204, BEKINDA(r) (RHB-102), YELIVA(r) (ABC294640), RHB-106 and RHB-107. The company also commercializes and promotes gastrointestinal products in the United States.

Contact Information

Website: www.redhillbio.com
Email: info@redhillbio.com
Main Phone: +972 35413131
Address: 21 Ha'arba'a Street
City / Town: Tel Aviv
Country: ISR
Postal Code: 64739

Issuer Information

Exchange: NSD
CEO: Dror Ben-Asher
Employees: 74
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 6.38 $ -0.42 (-6.18%)
Last Price 6.38 Change $ -0.42 Change % -6.18 Tick N/A
Bid 6.25 Bid Size 500.00 Ask 6.37 Ask Size 1,000.00
Open 6.81 High 7.00 Low 6.28 Prev Close 6.80
Last Trade Volume 328,941 52 Wk Hi 11.49 52 Wk Low 4.40
Market Cap 162.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 25,511,547.00 EPS (TTM) -1.90 PE Ratio N/A Exchange NSD
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 36 36 36 36
Low Target Price Estimate 17 17 17 17
Mean Target Price Estimate 24 24 24 24
Standard Deviation 10.44 10.44 10.44 10.44
Date of Most Recent Estimate 05/14/18 05/14/18 05/14/18 05/14/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1